*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.
GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.
The association between miRNAs and cancer has become one of the most intense areas of interest in biomedicine. Key goals are to help determine the prognosis of a cancer patient once diagnosed and develop the most promising course of therapy.
During this week's GEN podcast, Dr. George Calin from M. D. Anderson provides additional details on why work on miRNAs has become such a hotbed of research activity in the life sciences. He notes the evidence of a significant role for miRNAs in cancer and discusses what he and his team call the "main paradigms" for the involvement of miRNAs in human cancers.
Dr. Calin also talks about the importance of genome-wide profiling in miRNA research and offers examples of how miRNA arrays and quantitative RT-PCR technologies are used in such genome-wide profiling studies. In addition, he explains the theoretical rationale for using miRNAs in cancer treatment.
George Adrian Calin received both his M.D.
and Ph.D. degrees at Carol Davila University
of Medicine in Bucharest, Romania.
After working cytogenetics as undergraduate student with Dr. Dragos
Stefanescu in Bucharest, he completed a cancer genomics training
in Dr. Massimo Negrini’s laboratory at University of Ferrara, Italy. In 2000
he became a postdoctoral fellow at Kimmel Cancer Center in
Philadelphia, PA, in Dr. Carlo Croce’s laboratory.
He is presently an Associate Professor in Experimental Therapeutics at
MDACC and studies the roles of microRNAs and other non-coding RNAs
in cancer initiation and progression, as well as the mechanisms of
cancer predisposition and explores new RNA therapeutic options for